IPCA Laboratories share price
You have to be logged in to add this to Watchlist.- ₹1,440.15(-1.17%)December 5, 2025 15:29:21 PM IST
- NSE
- BSE
- Vol : 248.70 K (NSE + BSE)Last 20 day avg : 553.73 K
IPCA Laboratories is trading -1.17% lower at Rs 1,440.15 as compared to its last closing price. IPCA Laboratories has been trading in the price range of 1,461.40 & 1,416.00. IPCA Laboratories has given -14.19% in this year & 4.20% in the last 5 days. IPCA Laboratories has TTM P/E ratio 40.84 as compared to the sector P/E of 32.51.There are 16 analysts who have initiated coverage on IPCA Laboratories. There are 6 analysts who have given it a strong buy rating & 6 analysts have given it a buy rating. 0.00 analysts have given the stock a sell rating.The company posted a net profit of 282.57 Crores in its last quarter.Listed peers of IPCA Laboratories include Divi's Laboratories (-0.04%), Torrent Pharmaceuticals (-0.74%), Sun Pharmaceutical Industries (-0.75%).The Mutual Fund holding in IPCA Laboratories was at 30.04% in 30 Sep 2025. The MF holding has increased from the last quarter. The FII holding in IPCA Laboratories was at 10.42% in 30 Sep 2025. The FII holding has decreased from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
Updated on Dec 06, 2025, 05:42 AM UTC
- BetaLow volatility0.70Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
- Debt To EquityHigher than industry0.20The debt-to-equity ratio, indicating a company's financial leverage.
- Dividend YieldLower than industry0.14Annual dividends as a percentage of the stock price.
- P/BHigher than historical values5.31The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
- P/EHigher than historical values44.37Price-to-earnings ratio based on trailing 12-month earnings
- PEG RatioIndicates undervaluation-7.58The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
|
| ||||
|
| ||||
Names | Technical rating | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|---|
| Divi's Laboratories | Bullish | 6,468.25 | -0.04 | 1,73,113.62 | 78.27 | 11.47 | 0.46 | 0.01 |
| Torrent Pharmaceuticals | Bullish | 3,773.70 | -0.74 | 1,27,661.97 | 66.64 | 16.92 | 0.84 | 17.62 |
| Sun Pharmaceutical Industries | Bullish | 1,805.00 | -0.75 | 4,33,140.85 | 37.94 | 6.04 | 0.88 | 0.50 |
| Dr Reddy's Laboratories | Bullish | 1,276.55 | -0.04 | 1,06,330.42 | 18.80 | 3.17 | 0.63 | 2.34 |
| Cipla | Neutral | 1,520.55 | -0.04 | 1,22,825.65 | 23.33 | 3.94 | 0.85 | 0.81 |
- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2025-11-13 | Quarterly Results |
| 2025-08-11 | Quarterly Results |
| 2025-05-29 | Audited Results & Final Dividend |
| 2025-02-13 | Quarterly Results |
| 2024-11-14 | Quarterly Results & Interim Dividend |
- IndustryBiotechnology & Drugs
- ISININE571A01038
- BSE Code524494
- NSE CodeIPCALAB
IPCA Laboratories is trading at 1440.15 as on Fri Dec 05 2025 09:59:21. This is -1.17% lower as compared to its previous closing price of 1457.15.
The market capitalization of IPCA Laboratories is 36534.49 Cr as on Fri Dec 05 2025 09:59:21.
The average broker rating on IPCA Laboratories is Buy. The breakup of analyst rating is given below -
- 6 analysts have given a strong buy rating
- 6 analysts have given a buy rating
- 3 analysts have given a hold rating
- 0.00 analysts have given a sell rating
- 1 analysts have given a strong sell rating
The 52 wk high for IPCA Laboratories is 1757.65 whereas the 52 wk low is 1200.00
IPCA Laboratories can be analyzed on the following key metrics -
- TTM P/E: 40.84
- Sector P/E: 32.51
- Dividend Yield: 0.14%
- D/E ratio: 0.17
IPCA Laboratories reported a net profit of 737.68 Cr in 2025.
The Mutual Fund Shareholding was 30.04% at the end of 30 Sep 2025.
EQUITY QUICK LINKS
IPCA Laboratories QUICK LINKS
FROM MARKETS
RELATED LINKS
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.